On December 17, 2020, NovelCath was acquired by Cirtec Medical, a strategic outsourcing partner for complex medical devices. This acquisition further strengthens Cirtec’s Interventional Device business which includes design and development, vertical integration of components, and full-device-assembly for both implantable devices and complex delivery systems. Together, we will continue to expand our innovative design and manufacturing services to help solve our customers' most complex medical device challenges.
NovelCath is a US based contract manufacturer of highly engineered catheter delivery systems based in the medical device alley of the Twin Cities MN. We specialize in the design, development and manufacturing of minimally invasive interventional delivery systems ranging from Structural Heart to Electrophysiology and Neurovascular applications. Our team is led by well known and trusted industry veterans with over 70 years of combined industry experience at solving complex steerable and multi-directional catheter shaft designs.
Our 14,000 square foot Minneapolis, MN facility is vertically integrated; assembling in a 3,200 sq. ft. class 7 clean room with dedicated prototyping lines, catheter assembly, extrusion, braiding, coiling
and multiple reflow technologies.
NovelCath’s R&D team focus on supporting customer early stage development programs with design consultation, quick turn prototyping for concept verification to supporting animal studies, while always recognizing the long term manufacturability requirements.